Colgate-Palmolive is a defensible global cash compounder whose margin recovery and SGPP savings can support modest upside despite tariffs, leverage, and near-term U.S. volume pressure.
Overview
Colgate-Palmolive is a global defensive consumer-products company operating in more than 200 countries and territories, with two main businesses: Oral, Personal, and Home Care, and Hill’s Pet Nutrition. The former generated $15.77 billion, or 77.37% of fiscal 2025 sales, while Pet Nutrition contributed $4.61 billion, or 22.63%. **Its moat is anchored by recurring essential consumption, professional recommendations, and leading market shares of 41.3% in global toothpaste and 32.7% in manual toothbrushes.** Q2 2026 net sales rose 4.9% to $5,361 million, organic sales increased 2.4%, and non-GAAP Base Business EPS grew 8% to $0.99, beating consensus by $0.04. Gross margin expanded 140 basis points to 61.5%, although GAAP EPS fell 5% to $0.86 because of $129 million in pre-tax restructuring charges. Management maintained 2026 sales guidance and raised Base Business EPS growth guidance to mid-single digits. The stock trades at 24.02x forward P/E and 15.9x EV/EBITDA, above peer medians, but the premium is supported by 17.8% free-cash-flow conversion, global scale, and resilient brands. The five-year probability-weighted target is $111.14 versus a current price of $91.35.